EVEROLIMUS
EVEROLIMUS TABLETS 0.75/5/10 MG
IndicationTreatment of adult patients with renal angiomyolipoma associated with Tuberous Sclerosis Complex (TSC).
Treatment of patients with subependymal giant cell (SEGA) associated with Tuberous Sclerosis Complex (TSC).